Successful use of citrate anticoagulant with heparin bolus for excessive clotting during extracorporeal photopheresis

被引：4
|
作者：
Weber, Litchia L. [1 ]
Dunbar, Nancy M. [1 ]
Dumont, Larry J. [1 ]
Szczepiorkowski, Zbigniew M. [1 ]
机构：
[1] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA
来源：
TRANSFUSION | 2012年 / 52卷 / 11期
关键词：
DEXTROSE;
D O I：
10.1111/j.1537-2995.2012.03846.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2494 / 2495
页数：2
相关论文
共 50 条
  • [1] Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: An effective protocol
    Nedelcu, Elena
    Ziman, Alyssa
    Fernando, Leonor P.
    Cook, Kris
    Bumerts, Pam
    Schiller, Gary
    JOURNAL OF CLINICAL APHERESIS, 2008, 23 (02) : 66 - 73
  • [2] Acid citrate dextrose extracorporeal photopheresis is an alternative treatment option for patients with heparin allergy
    Stadler, Simone
    Booken, Nina
    Schneider, Stefan W.
    Goerdt, Sergij
    Klemke, Claus-Detlev
    Utikal, Jochen
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (07) : E266 - E267
  • [3] Using Anticoagulant Citrate Dextrose Solution (ACDA) as the standard anticoagulation in Extracorporeal Photopheresis (ECP) treatments
    Gellatly, Craig
    Fotheringham, June
    Anderson, Moira
    BONE MARROW TRANSPLANTATION, 2018, 53 : 857 - 857
  • [4] CITRATE TOXICITY AND USE OF ANTICOAGULANT ACID CITRATE DEXTROSE BLOOD FOR EXTRACORPOREAL CIRCULATION
    JENNINGS, ER
    BELAND, AJ
    COPE, JA
    ELLESTAD, MH
    MONROE, C
    SHADLE, OW
    SURGERY GYNECOLOGY AND OBSTETRICS WITH INTERNATIONAL ABSTRACTS OF SURGERY, 1965, 120 (05): : 997 - +
  • [5] SUCCESSFUL USE OF EXTRACORPOREAL PHOTOPHERESIS AS THERAPY FOR ANTIBODY-MEDIATED REJECTION
    Benazzo, A.
    Schwarz, S.
    Murakozy, G.
    Lambers, C.
    Moser, B.
    Matilla, J. S.
    Lang, G.
    Taghavi, S.
    Klepetko, W.
    Hoetzenecker, K.
    Jaksch, P.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 20 - 20
  • [6] Real-world evidence of heparin and citrate use in extracorporeal photopheresis: A hypothesis-generating data review of device settings and performance
    Connelly-Smith, Laura S.
    Griffin, James
    Leung, Albert T.
    Gennari, Francesca
    JOURNAL OF CLINICAL APHERESIS, 2024, 39 (01)
  • [7] ACTIVATED CLOTTING TIME, ANTICOAGULATION, USE OF HEPARIN, AND THROMBIN ACTIVATION DURING EXTRACORPOREAL-CIRCULATION - CHANGES UNDER APROTININ THERAPY
    FEINDT, P
    VOLKMER, I
    SEYFERT, U
    HUWER, H
    KALWEIT, G
    GAMS, E
    THORACIC AND CARDIOVASCULAR SURGEON, 1993, 41 (01): : 9 - 15
  • [8] Repeated Premature Hemofilter Clotting During Regional Citrate Anticoagulation as Indicator of Heparin Induced Thrombocytopenia
    Lehner, Georg F.
    Schoepf, Marion
    Harler, Ulrich
    Pechlaner, Christoph
    Joannidis, Michael
    BLOOD PURIFICATION, 2014, 38 (02) : 127 - 130
  • [9] Successful use of argatroban in pediatric patients requiring anticoagulant alternatives to heparin.
    Tcheng, WY
    Wong, WY
    BLOOD, 2004, 104 (11) : 107B - 108B
  • [10] Use of Nafamostat Mesilate as an Anticoagulant during Extracorporeal Membrane Oxygenation
    Han, Sang Jin
    Kim, Hyoung Soo
    Kim, Kun Il
    Whang, Sung Mi
    Hong, Kyung Soon
    Lee, Won Ki
    Lee, Sun Hee
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (07) : 945 - 950
12345